U.S. markets closed

INVO Bioscience, Inc. (INVO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0769-0.1831 (-14.53%)
At close: 04:00PM EDT

INVO Bioscience, Inc.

5582 Broadcast Court
Sarasota, FL 34240
United States
978 878 9505

IndustryMedical Devices
Full Time Employees10

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven M. ShumCEO & Director297.5kN/A1971
Mr. Andrea GorenChief Financial Officer247.73kN/A1967
Mr. Michael Jos. CampbellCOO & VP of Bus. Devel.330kN/A1958
Dr. Kevin Doody M.D.Medical Director & Director25kN/A1959
Mr. Bojan Mitrovic Ph.D.Director of Sales USN/AN/AN/A
Dr. Barbara Levy F.A.C.S., FACOG, M.D.Sr. VP of Global Clinical IntegrationN/AN/AN/A
Mr. Chris MyerSr. VP of Bus. Devel. of AmericasN/AN/AN/A
Mr. Robert Joseph Bowdring Jr.Treasurer & Sec.N/AN/A1958
Ms. Terah KrigsvoldControllerN/AN/AN/A
Ms. Lori Marzilli-KahlerVP of Global OperationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Corporate Governance

INVO Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.